Download Free Sample Report

The global Anti-Inflammatory Analgesic and Antipyretic Drugs market was valued at US$ 2789.5 million in 2022 and is projected to reach US$ 3123.1 million by 2029, at a CAGR of 1.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Anti-Inflammatory Analgesic and Antipyretic Drug can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
This report aims to provide a comprehensive presentation of the global market for Anti-Inflammatory Analgesic and Antipyretic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Inflammatory Analgesic and Antipyretic Drugs. This report contains market size and forecasts of Anti-Inflammatory Analgesic and Antipyretic Drugs in global, including the following market information:

• Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
• Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Sales, 2018-2023, 2024-2029, (Tons)
• Global top five Anti-Inflammatory Analgesic and Antipyretic Drugs companies in 2022 (%)

Shandong Xinhua Pharmaceutical Company Limited and Mallinckrodt Pharmaceuticals are the top 2 manufacturers of antipyretic and analgesic raw materials globally and holds over 30% of global market share in total. Geographically speaking, North America holds about 25% of total market share, followed by China with over 20% share. In terms of type, paracetamol segment holds over half of total market share, followed by ibuprofen with over 20% share. In terms of end users, adult segment holds a dominant share of over 70%.
We surveyed the Anti-Inflammatory Analgesic and Antipyretic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Segment Percentages, by Type, 2022 (%)

• Paracetamol
• Aspirin
• Ibuprofen
• Naproxen
• Diclofenac
• Oxaprozin
• Dexibuprofen
• Others

Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Segment Percentages, by Application, 2022 (%)

• Adults
• Children

Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Inflammatory Analgesic and Antipyretic Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Inflammatory Analgesic and Antipyretic Drugs revenues share in global market, 2022 (%)
Key companies Anti-Inflammatory Analgesic and Antipyretic Drugs sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Anti-Inflammatory Analgesic and Antipyretic Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Mallinckrodt Pharmaceuticals
• IOL
• Anqiu Lu'an Pharmaceutical
• Novacyl
• BASF
• Anhui BBCA Pharmaceuticals
• Hubei Biocause
• Xinhua Pharm
• Granules India Limited
• Huagang Pharm
• Hebei Jiheng Pharmaceutical
• Zhejiang Kangle Pharmaceutical
• Hebei Jingye Medical Technology
• MSPF
• Lu'an Pharmaceutical
• Mallinckrodt
• Farmson
• Anhui Fubore
• SKPL
• Atabay
• Huzhou Konch Pharmaceutical
• Anhui Topsun
• SOLARA
• SI Group

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Anti-Inflammatory Analgesic and Antipyretic Drugs, market overview.
• Chapter 2: Global Anti-Inflammatory Analgesic and Antipyretic Drugs market size in revenue and volume.
• Chapter 3: Detailed analysis of Anti-Inflammatory Analgesic and Antipyretic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Anti-Inflammatory Analgesic and Antipyretic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global Anti-Inflammatory Analgesic and Antipyretic Drugs capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.